Clinical trial · Observational
MRI-Guided Cryoablation for Focal Native Prostate Cancer
NCT04797039CI-TRIAL-00110783recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed. Participants have been asked to take part in this research because the participants have been diagnosed with prostate cancer and scheduled to have an ablation procedure.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Primary Malignant Neoplasm of Prostate (Diagnosis) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MR guided cryoablation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- MR guided cryoablation
- description
- Focal MR guided cryoablation for low- to intermediate-grade prostate cancer
- interventionNames
- Procedure: MR guided cryoablation
Primary outcomes (3)
- measure
- Technical success of the MR-guided cryoablation
- timeFrame
- Will assess for 5 years with interval assessment each year
- description
- Determine the technical success of the MR-guided cryoablation as measured by complete target lesion ablation.
- measure
- Safety of the MR-guided cryoablation
- timeFrame
- Will assess for 5 years with interval assessment each year
- description
- Determine safety of the MR-guided cryoablation using continuous MR imaging during the procedure.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 30 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with "biopsy proven" Gleason7 prostate cancer referred to Urology and/or Interventional Radiology for treatment * Surgery and/or Radiation is not a desirable alternative therapy at the time of enrollment * Tumor size is \< 2 cm at its largest diameter * Tumor does not encompass the rectal wall or external urethral sphincter * Patient is able to undergo MRI Exclusion Criteria: •
References
Publications (0)
Data not yet available
No reference posted for this study.